DDrare: Database of Drug Development for Rare Diseases

Procedure: fmt (DrugBank: -)

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
97	潰瘍性大腸炎	1

96. クローン病　［臨床試験数：2,209，薬物数：1,276（DrugBank：240），標的遺伝子数：166，標的パスウェイ数：210］

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,209 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02335281 (ClinicalTrials.gov)	January 2015	7/1/2015	Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease	Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel Disease	Inflammatory Bowel Disease;Ulcerative Colitis;Crohn's Disease	Procedure: FMT;Drug: Mesalazine	Yanling Wei	NULL	Recruiting	16 Years	70 Years	Both	40	Phase 2	China

97. 潰瘍性大腸炎　［臨床試験数：2,269，薬物数：1,331（DrugBank：241），標的遺伝子数：114，標的パスウェイ数：181］

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,269 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02335281 (ClinicalTrials.gov)	January 2015	7/1/2015	Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease	Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel Disease	Inflammatory Bowel Disease;Ulcerative Colitis;Crohn's Disease	Procedure: FMT;Drug: Mesalazine	Yanling Wei	NULL	Recruiting	16 Years	70 Years	Both	40	Phase 2	China